InvestorsHub Logo
Followers 28
Posts 1910
Boards Moderated 0
Alias Born 08/09/2010

Re: MrLong post# 55776

Thursday, 03/17/2011 11:25:19 AM

Thursday, March 17, 2011 11:25:19 AM

Post# of 105534
I started following CB AI a while back and didn't invest until I thought I had a pretty good handle on the simple stem cell business model of storage as a family insurance policy. As the insurance companies endorsement added backing in this field I started added to my investment. I truly thought the dilution was over. I never thought this was a quick buck and new Matt had tough competition. Acquiring distressed assets from other companies in order to grow market share or profitability is not as easy as one might think. I was very much involved with a high tech company that used my money/shares for this approach and destroyed a good core product because in the end they didn't have enough money to do what they did best. My hopes for CBAI during the growing pains of fighting for storage clients was that Matt would align the company with the research and development side of the growing stem cell medical use. It is hard enough to get info on CBAI relationships in the US, how can I read what will come out of the China Lab relationship? Penny stocks and their foreign relationships make for good press releases but often do little for the bottom line and allow insiders to sell a lot of shares. Some of my big concerns with the stem cell storage model is that the technology is changing rapidly and may hold a future that just doesn't need it. Matt is trying to buy his way into a business model that can easily be recreated by companies with deep pockets unless he's smarter than the folks whos assets he's buying.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.